Event Type
Disclosure
Voluntary
Variant
8-K
Other Events. On August 13, 2025, Lixte Biotechnology Holdings, Inc. (the “Company”) issued a news release announcing that it had updated its corporate treasury
Financial Statements and Exhibits. (d) Exhibits The Company is filing as part of this Current Report on Form 8-K the exhibits listed on the accompanying Index t